Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis
| Image |  |
|---|---|
| Description | scientific article published on 24 August 2017 |
| Author/s |
author: Kathryn E. Flynn Mehdi Hamadani |
| Publication date | August 24, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |